Robert Kennedy
Internal Medicine · Huntsville, ALNPI 1487278909
Payments from drug & device makers
Across 52 payments — averaging $35.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Novo Nordisk$155
- Corcept Therapeutics$46
- Recordati_rare_diseases_inc.$42
- Bayer$41
- Boehringer Ingelheim$37
- plus $340 from 15 others
What the payments were for
- Travel & lodging$70238%
- Food & beverage$1,14462%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 23 | $1,186 |
| Novo Nordisk | 4 | $155 |
| Corcept Therapeutics | 2 | $46 |
| Recordati_rare_diseases_inc. | 2 | $42 |
| Bayer | 2 | $41 |
| Boehringer Ingelheim | 2 | $37 |
| Dexcom, Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Nevro Corp. | 1 | $31 |
| Averitas Pharma Inc. | 1 | $29 |
| Chiesi USA, Inc. | 1 | $28 |
| Theratechnologies Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Madrigal Pharmaceuticals | 1 | $22 |
| Aurinia Pharma U.S., Inc. | 1 | $17 |
| Insulet Corporation | 1 | $17 |
| Tandem Diabetes Care, Inc. | 1 | $17 |
| Amgen | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Mannkind Corporation | 1 | $15 |
| Rhythm Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$796
- Ozempic$114
How this compares
$1,846 in reported general payments places this provider in the 70th percentile of 1,533 internal medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 43 | $215 |
| Alendronate Sodium | 18 | $128 |
| Methimazole | 13 | $125 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Huntsville
- Saadat AnsariHuntsville$2.1M
- Tiffany Schwasinger-SchmidtHuntsville$787K
- John ClarkHuntsville$756K
- Palak ShahHuntsville$49K
- Joseph HastieHuntsville$44K
- Harry StuddardMobile$12.9M
- Almena FreeAnniston$12.7M
- Hayes WilliamsVestavia$10.4M
- David DeatkineBirmingham$8M
- James SullivanBirmingham$6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.